scholarly journals Regional Differences in Blood-Brain Barrier Permeability Changes and Inflammation in the Apathogenic Clearance of Virus from the Central Nervous System

2006 ◽  
Vol 176 (12) ◽  
pp. 7666-7675 ◽  
Author(s):  
Timothy W. Phares ◽  
Rhonda B. Kean ◽  
Tatiana Mikheeva ◽  
D. Craig Hooper
2020 ◽  
Author(s):  
Sylvia Carina Van Belle ◽  
Anja de Lange ◽  
Hayley Tomes ◽  
Rodney Lucas ◽  
Vinogran Naidoo ◽  
...  

Human cysticercosis is a disease caused by larvae of the cestode Taenia solium. It is the most common cause of adult-acquired epilepsy world-wide where it exacts a debilitating toll on the health and well-being of affected communities. It is commonly assumed that the major symptoms associated with cysticercosis are a result of the direct presence of larvae in the brain. As a result, the possible effect of peripherally located larvae on the central nervous system are not well understood. To address this question, we utilised the Taenia crassiceps intra-peritoneal murine model of cysticercosis, where larvae are restricted to the peritoneal cavity. In this model, previous research has observed behavioural changes in rodents but not the development of seizures. Here we used ELISAs, immunoblotting and the Evans Blue test for blood-brain barrier permeability to explore the central effects of peripheral infection of mice with Taenia crassiceps. We identified high levels of parasite-targeting immunoglobulins in the serum of Taenia crassiceps infected mice. We show that the Taenia crassciceps larvae themselves also contain and release host immunoglobulins over time. Additionally, we describe, for the first time, significantly increased levels of IgG within the hippocampi of infected mice, which are accompanied by changes in blood-brain barrier permeability. However, these Taenia crassiceps induced changes were not accompanied by alterations to the levels of proinflammatory, pro-seizure cytokines in the hippocampus. These findings contribute to the understanding of systemic and neuroimmune responses in the Taenia crassiceps model of cysticercosis, with implications for the pathogenesis of human cysticercosis.


2018 ◽  
Vol 33 (4) ◽  
pp. 590-598 ◽  
Author(s):  
Yude Liu ◽  
Lian Rao ◽  
Hongguan Zhang ◽  
Yanyou Cen ◽  
Kaili Cheng

Herb borneol is usually used in clinics for the treatment of central nervous system illness, for its ability of blood–brain barrier permeability, although its poor water solubility and poor bioavailability limit its clinical application to some degree. In this study, we developed a novel nanoparticle combining the benefits of vitamin E d-ɑ-tocopheryl poly(ethylene glycol) succinate (E-TPGS) (or TPGS) and guar gum to get TPGS-g-guar gum as a drug delivery system to carry borneol, which could improve the solubility of borneol and increase the drug-loading capacity efficiently. The results showed that TPGS-g-guar gum nanoparticles delivery system was suitable to carry borneol and release the drug effectively, and TPGS-g-guar gum/borneol nanoparticles would be a potential platform for improving the treatment of central nervous system illness and cerebrovascular disease.


Neurosurgery ◽  
1992 ◽  
Vol 30 (6) ◽  
pp. 882-886 ◽  
Author(s):  
Antonino Germanó ◽  
Domenico dʼAvella ◽  
Rocco Cicciarello ◽  
Ronald L. Hayes ◽  
Francesco Tomasello

Sign in / Sign up

Export Citation Format

Share Document